Larry Schlesinger - Publications

Affiliations: 
Integrated Biomedical Sciences Ohio State University, Columbus, Columbus, OH 
Area:
Molecular Biology, Microbiology Biology

77/215 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Arnett E, Wolff J, Leopold Wager CM, Simper J, Badrak JL, Ontiveros CO, Ni B, Schlesinger LS. Cutting Edge: Cytosolic Receptor AIM2 Is Induced by Peroxisome Proliferator-activated Receptor γ following Mycobacterium tuberculosis Infection of Human Macrophages but Does Not Contribute to IL-1β Release. Journal of Immunology (Baltimore, Md. : 1950). PMID 38251918 DOI: 10.4049/jimmunol.2300418  0.329
2024 Olmo-Fontánez AM, Scordo JM, Schami A, Garcia-Vilanova A, Pino PA, Hicks A, Mishra R, Jose Maselli D, Peters JI, Restrepo BI, Nargan K, Naidoo T, Clemens DL, Steyn AJC, Thacker VV, ... ... Schlesinger LS, et al. Human alveolar lining fluid from the elderly promotes Mycobacterium tuberculosis intracellular growth and translocation into the cytosol of alveolar epithelial cells. Mucosal Immunology. PMID 38185331 DOI: 10.1016/j.mucimm.2024.01.001  0.38
2023 Arnett E, Pahari S, Leopold Wager CM, Hernandez E, Bonifacio JR, Lumbreras M, Renshaw C, Montoya MJ, Opferman JT, Schlesinger LS. Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 168: 115738. PMID 37864894 DOI: 10.1016/j.biopha.2023.115738  0.303
2023 Sadee W, Cheeseman IH, Papp A, Pietrzak M, Seweryn M, Zhou X, Lin S, Williams AM, Wewers MD, Curry HM, Zhang H, Cai H, Kunsevi-Kilola C, Tshivhula H, Walzl G, ... ... Schlesinger LS, et al. Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability. Research Square. PMID 37333188 DOI: 10.21203/rs.3.rs-2986649/v1  0.334
2023 Leopold Wager CM, Bonifacio JR, Simper J, Naoun AA, Arnett E, Schlesinger LS. Activation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling. Plos Pathogens. 19: e1011297. PMID 37000865 DOI: 10.1371/journal.ppat.1011297  0.395
2022 Simper JD, Perez E, Schlesinger LS, Azad AK. Resistance and Susceptibility Immune Factors at Play during Infection of Macrophages. Pathogens (Basel, Switzerland). 11. PMID 36297211 DOI: 10.3390/pathogens11101153  0.358
2022 Jurkowitz MS, Azad AK, Monsma PC, Keiser TL, Kanyo J, Lam TT, Bell CE, Schlesinger LS. Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids. The Journal of Biological Chemistry. 101849. PMID 35314194 DOI: 10.1016/j.jbc.2022.101849  0.745
2022 Singh DK, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger LS, Artyomov MN, Khader SA, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Nature Communications. 13: 679. PMID 35115549 DOI: 10.1038/s41467-022-28315-7  0.34
2022 Allué-Guardia A, Garcia-Vilanova A, Olmo-Fontánez AM, Peters J, Maselli DJ, Wang Y, Turner J, Schlesinger LS, Torrelles JB. Host- and Age-Dependent Transcriptional Changes in Cell Envelope Biosynthesis Genes after Exposure to Human Alveolar Lining Fluid. International Journal of Molecular Sciences. 23. PMID 35055170 DOI: 10.3390/ijms23020983  0.313
2021 Singh B, Singh DK, Ganatra SR, Escobedo RA, Khader S, Schlesinger LS, Kaushal D, Mehra S. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. Mbio. e0318921. PMID 34903057 DOI: 10.1128/mbio.03189-21  0.309
2021 Allué-Guardia A, Garcia-Vilanova A, M Olmo-Fontánez A, Peters J, Maselli DJ, Wang Y, Turner J, Schlesinger LS, Torrelles JB. Host- and age-dependent transcriptional changes in cell envelope biosynthesis genes after exposure to human alveolar lining fluid. Biorxiv : the Preprint Server For Biology. PMID 34580670 DOI: 10.1101/2021.09.08.459334  0.311
2021 Singh D, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger L, Artyomov M, Khader S, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Research Square. PMID 34282414 DOI: 10.21203/rs.3.rs-664507/v1  0.315
2021 Piergallini TJ, Scordo JM, Pino PA, Schlesinger LS, Torrelles JB, Turner J. Acute Inflammation Confers Enhanced Protection against Mycobacterium tuberculosis Infection in Mice. Microbiology Spectrum. e0001621. PMID 34232086 DOI: 10.1128/Spectrum.00016-21  0.358
2020 Bartlett S, Gemiarto AT, Ngo MD, Sajiir H, Hailu S, Sinha R, Foo CX, Kleynhans L, Tshivhula H, Webber T, Bielefeldt-Ohmann H, West NP, Hiemstra AM, MacDonald CE, Christensen LVV, ... Schlesinger LS, et al. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Infection and Is Associated With TB Disease Severity. Frontiers in Immunology. 11: 601534. PMID 33240287 DOI: 10.3389/fimmu.2020.601534  0.328
2020 Crouser ED, Locke LW, Julian MW, Bicer S, Sadee W, White P, Schlesinger LS. Phagosome-regulated mTOR Signalling during Sarcoidosis Granuloma Biogenesis. The European Respiratory Journal. PMID 32943400 DOI: 10.1183/13993003.02695-2020  0.315
2020 Sivangala Thandi R, Radhakrishnan RK, Tripathi D, Paidipally P, Azad AK, Schlesinger LS, Samten B, Mulik S, Vankayalapati R. Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection. Nature Communications. 11: 3535. PMID 32669568 DOI: 10.1038/s41467-020-17310-5  0.323
2019 Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger LS, Agrewala JN. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of . Autophagy. PMID 31462144 DOI: 10.1080/15548627.2019.1658436  0.304
2019 Leopold Wager CM, Arnett E, Schlesinger LS. Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know. Tuberculosis (Edinburgh, Scotland). PMID 31060958 DOI: 10.1016/j.tube.2019.04.016  0.382
2019 Moliva JI, Duncan MA, Olmo-Fontánez A, Akhter A, Arnett E, Scordo JM, Ault R, Sasindran SJ, Azad AK, Montoya MJ, Reinhold-Larsson N, Rajaram MVS, Merrit RE, Lafuse WP, Zhang L, ... ... Schlesinger LS, et al. The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection. The Journal of Infectious Diseases. PMID 30923818 DOI: 10.1093/Infdis/Jiz138  0.346
2018 Guirado E, Rajaram MV, Chawla A, Daigle J, La Perle KM, Arnett E, Turner J, Schlesinger LS. Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice. Tuberculosis (Edinburgh, Scotland). 111: 170-177. PMID 30029904 DOI: 10.1016/J.Tube.2018.06.012  0.382
2018 Arnett E, Weaver AM, Woodyard KC, Montoya MJ, Li M, Hoang KV, Hayhurst A, Azad AK, Schlesinger LS. PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis. Plos Pathogens. 14: e1007100. PMID 29928066 DOI: 10.1371/journal.ppat.1007100  0.386
2018 Papp AC, Azad AK, Pietrzak M, Williams A, Handelman SK, Igo RP, Stein CM, Hartmann K, Schlesinger LS, Sadee W. AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection. Plos One. 13: e0198221. PMID 29847580 DOI: 10.1371/journal.pone.0198221  0.374
2018 Garfoot AL, Goughenour KD, Wüthrich M, Rajaram MVS, Schlesinger LS, Klein BS, Rappleye CA. O-Mannosylation of Proteins Enables Histoplasma Yeast Survival at Mammalian Body Temperatures. Mbio. 9. PMID 29295913 DOI: 10.1128/Mbio.02121-17  0.303
2017 Pyle CJ, Azad AK, Papp AC, Sadee W, Knoell DL, Schlesinger LS. Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis. International Journal of Molecular Sciences. 18. PMID 29120360 DOI: 10.3390/ijms18112375  0.392
2017 Lavalett L, Rodriguez H, Ortega H, Sadee W, Schlesinger LS, Barrera LF. Alveolar macrophages from tuberculosis patients display an altered inflammatory gene expression profile. Tuberculosis (Edinburgh, Scotland). 107: 156-167. PMID 29050765 DOI: 10.1016/j.tube.2017.08.012  0.338
2017 Rajaram MVS, Arnett E, Azad AK, Guirado E, Ni B, Gerberick AD, He LZ, Keler T, Thomas LJ, Lafuse WP, Schlesinger LS. M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1. Cell Reports. 21: 126-140. PMID 28978467 DOI: 10.1016/J.Celrep.2017.09.034  0.336
2017 Wright CC, Hsu FF, Arnett E, Dunaj JL, Davidson PM, Pacheco SA, Harriff MJ, Lewinsohn DM, Schlesinger LS, Purdy GE. The Mycobacterium tuberculosis MmpL11 cell wall lipid transporter is important for biofilm formation, intracellular growth and non-replicating persistence. Infection and Immunity. PMID 28507063 DOI: 10.1128/Iai.00131-17  0.37
2016 Schorey JS, Schlesinger LS. Innate Immune Responses to Tuberculosis. Microbiology Spectrum. 4. PMID 28087945 DOI: 10.1128/Microbiolspec.Tbtb2-0010-2016  0.392
2016 Dodd CE, Pyle CJ, Glowinski R, Rajaram MV, Schlesinger LS. CD36-Mediated Uptake of Surfactant Lipids by Human Macrophages Promotes Intracellular Growth of Mycobacterium tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). 197: 4727-4735. PMID 27913648 DOI: 10.4049/jimmunol.1600856  0.329
2016 Zimmermann N, Thormann V, Hu B, Köhler AB, Imai-Matsushima A, Locht C, Arnett E, Schlesinger LS, Zoller T, Schürmann M, Kaufmann SH, Wardemann H. Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis. Embo Molecular Medicine. PMID 27729388 DOI: 10.15252/emmm.201606330  0.301
2016 Hao W, Schlesinger LS, Friedman A. Modeling Granulomas in Response to Infection in the Lung. Plos One. 11: e0148738. PMID 26986986 DOI: 10.1371/Journal.Pone.0148738  0.338
2015 Landes MB, Rajaram MV, Nguyen H, Schlesinger LS. Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages. Journal of Leukocyte Biology. 97: 1111-9. PMID 25801769 DOI: 10.1189/jlb.3A1114-557R  0.417
2015 Guirado E, Mbawuike U, Keiser TL, Arcos J, Azad AK, Wang SH, Schlesinger LS. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. Mbio. 6: e02537-14. PMID 25691598 DOI: 10.1128/Mbio.02537-14  0.755
2015 Pasula R, Azad AK, Gardner JC, Schlesinger LS, McCormack FX. Keratinocyte growth factor administration attenuates murine pulmonary mycobacterium tuberculosis infection through granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent macrophage activation and phagolysosome fusion. The Journal of Biological Chemistry. 290: 7151-9. PMID 25605711 DOI: 10.1074/jbc.M114.591891  0.347
2015 Behr M, Ellis R, Ernst J, Evans T, Flynn J, Hatherill M, Hoft D, Lalvani A, McShane H, Nardell E, Ordway D, Ramanathan R, Ruhwald M, Schlesinger L, Self S, et al. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings. National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014. Vaccine. 33: 3056-3064. DOI: 10.1016/J.Vaccine.2015.03.061  0.331
2014 Rajaram MV, Ni B, Dodd CE, Schlesinger LS. Macrophage immunoregulatory pathways in tuberculosis. Seminars in Immunology. 26: 471-85. PMID 25453226 DOI: 10.1016/j.smim.2014.09.010  0.405
2014 Gillette DD, Curry HM, Cremer T, Ravneberg D, Fatehchand K, Shah PA, Wewers MD, Schlesinger LS, Butchar JP, Tridandapani S, Gavrilin MA. Virulent Type A Francisella tularensis actively suppresses cytokine responses in human monocytes. Frontiers in Cellular and Infection Microbiology. 4: 45. PMID 24783062 DOI: 10.3389/Fcimb.2014.00045  0.307
2014 Restrepo BI, Twahirwa M, Rahbar MH, Schlesinger LS. Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. Plos One. 9: e92977. PMID 24671137 DOI: 10.1371/Journal.Pone.0092977  0.31
2014 Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA. N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis. The Journal of Infectious Diseases. 209: 1045-54. PMID 24265438 DOI: 10.1093/infdis/jit622  0.381
2013 Guirado E, Schlesinger LS, Kaplan G. Macrophages in tuberculosis: friend or foe. Seminars in Immunopathology. 35: 563-83. PMID 23864058 DOI: 10.1007/s00281-013-0388-2  0.41
2013 Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Frontiers in Immunology. 4: 98. PMID 23626591 DOI: 10.3389/fimmu.2013.00098  0.388
2013 Yang L, Sinha T, Carlson TK, Keiser TL, Torrelles JB, Schlesinger LS. Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth. Glycobiology. 23: 926-34. PMID 23576535 DOI: 10.1093/Glycob/Cwt029  0.745
2013 Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. Plos Pathogens. 9: e1003114. PMID 23359218 DOI: 10.1371/journal.ppat.1003114  0.313
2012 Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. American Journal of Physiology. Lung Cellular and Molecular Physiology. 303: L608-16. PMID 22886503 DOI: 10.1152/ajplung.00067.2012  0.325
2011 Rajaram MV, Ni B, Morris JD, Brooks MN, Carlson TK, Bakthavachalu B, Schoenberg DR, Torrelles JB, Schlesinger LS. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proceedings of the National Academy of Sciences of the United States of America. 108: 17408-13. PMID 21969554 DOI: 10.1073/Pnas.1112660108  0.348
2011 Keiser TL, Azad AK, Guirado E, Bonacci R, Schlesinger LS. Comparative transcriptional study of the putative mannose donor biosynthesis genes in virulent Mycobacterium tuberculosis and attenuated Mycobacterium bovis BCG strains. Infection and Immunity. 79: 4668-73. PMID 21896775 DOI: 10.1128/Iai.05635-11  0.753
2011 Torrelles JB, Sieling PA, Arcos J, Knaup R, Bartling C, Rajaram MV, Stenger S, Modlin RL, Schlesinger LS. Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses. The Journal of Biological Chemistry. 286: 35438-46. PMID 21859718 DOI: 10.1074/Jbc.M111.232587  0.308
2011 Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB. Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. Journal of Immunology (Baltimore, Md. : 1950). 187: 372-81. PMID 21602490 DOI: 10.4049/Jimmunol.1100823  0.357
2011 Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinburgh, Scotland). 91: 314-21. PMID 21482189 DOI: 10.1016/J.Tube.2011.03.003  0.344
2011 Brooks MN, Rajaram MV, Azad AK, Amer AO, Valdivia-Arenas MA, Park JH, Núñez G, Schlesinger LS. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cellular Microbiology. 13: 402-18. PMID 21040358 DOI: 10.1111/j.1462-5822.2010.01544.x  0.413
2010 Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 929-42. PMID 20554962 DOI: 10.4049/jimmunol.1000866  0.363
2010 Mohapatra NP, Soni S, Rajaram MV, Dang PM, Reilly TJ, El-Benna J, Clay CD, Schlesinger LS, Gunn JS. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 184: 5141-50. PMID 20348422 DOI: 10.4049/Jimmunol.0903413  0.718
2010 Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinburgh, Scotland). 90: 84-93. PMID 20199890 DOI: 10.1016/j.tube.2010.02.003  0.433
2010 Clay CD, Gunn JS, Schlesinger LS. Antibody-independent classical complement pathway activation by wildtype and LPS O-antigen mutant Francisella tularensis strains Molecular Immunology. 47: 2245-2245. DOI: 10.1016/J.Molimm.2010.05.146  0.7
2009 Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, Elton TS, Gunn JS, Amer A, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. Plos One. 4: e8508. PMID 20041145 DOI: 10.1371/Journal.Pone.0008508  0.706
2009 Day J, Friedman A, Schlesinger LS. Modeling the immune rheostat of macrophages in the lung in response to infection. Proceedings of the National Academy of Sciences of the United States of America. 106: 11246-51. PMID 19549875 DOI: 10.1016/J.Jcrc.2009.06.020  0.419
2009 Premanandan C, Storozuk CA, Clay CD, Lairmore MD, Schlesinger LS, Phipps AJ. Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages. Microbial Pathogenesis. 46: 306-14. PMID 19328844 DOI: 10.1016/J.Micpath.2009.03.004  0.716
2009 Torrelles JB, DesJardin LE, MacNeil J, Kaufman TM, Kutzbach B, Knaup R, McCarthy TR, Gurcha SS, Besra GS, Clegg S, Schlesinger LS. Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology. 19: 743-55. PMID 19318518 DOI: 10.1093/Glycob/Cwp042  0.396
2008 Clay CD, Soni S, Gunn JS, Schlesinger LS. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. Journal of Immunology (Baltimore, Md. : 1950). 181: 5568-78. PMID 18832715  0.726
2008 Torrelles JB, Knaup R, Kolareth A, Slepushkina T, Kaufman TM, Kang P, Hill PJ, Brennan PJ, Chatterjee D, Belisle JT, Musser JM, Schlesinger LS. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. The Journal of Biological Chemistry. 283: 31417-28. PMID 18784076 DOI: 10.1074/Jbc.M806350200  0.319
2008 Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, Marsh CB, Schlesinger LS, Tridandapani S. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. Plos One. 3: e2924. PMID 18698339 DOI: 10.1371/Journal.Pone.0002924  0.745
2008 Van Zandt KE, Sow FB, Florence WC, Zwilling BS, Satoskar AR, Schlesinger LS, Lafuse WP. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. Journal of Leukocyte Biology. 84: 689-700. PMID 18586980 DOI: 10.1189/Jlb.1107781  0.366
2008 Parsa KV, Butchar JP, Rajaram MV, Cremer TJ, Gunn JS, Schlesinger LS, Tridandapani S. Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Molecular Immunology. 45: 3428-37. PMID 18514317 DOI: 10.1016/J.Molimm.2008.04.006  0.336
2008 Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS. Role of C-type lectins in mycobacterial infections. Current Drug Targets. 9: 102-12. PMID 18288961 DOI: 10.2174/138945008783502467  0.349
2007 Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology. 82: 934-45. PMID 17609338 DOI: 10.1189/Jlb.0407216  0.33
2007 Butchar JP, Rajaram MV, Ganesan LP, Parsa KV, Clay CD, Schlesinger LS, Tridandapani S. Francisella tularensis induces IL-23 production in human monocytes. Journal of Immunology (Baltimore, Md. : 1950). 178: 4445-54. PMID 17372002 DOI: 10.4049/Jimmunol.178.7.4445  0.721
2007 Mohapatra NP, Balagopal A, Soni S, Schlesinger LS, Gunn JS. AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infection and Immunity. 75: 390-6. PMID 17060465 DOI: 10.1128/IAI.01226-06  0.324
2006 Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. Journal of Immunology (Baltimore, Md. : 1950). 177: 1805-16. PMID 16849491  0.325
2006 Parsa KV, Ganesan LP, Rajaram MV, Gavrilin MA, Balagopal A, Mohapatra NP, Wewers MD, Schlesinger LS, Gunn JS, Tridandapani S. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. Plos Pathogens. 2: e71. PMID 16848641 DOI: 10.1371/Journal.Ppat.0020071  0.322
2006 Hall-Stoodley L, Watts G, Crowther JE, Balagopal A, Torrelles JB, Robison-Cox J, Bargatze RF, Harmsen AG, Crouch EC, Schlesinger LS. Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions. Infection and Immunity. 74: 3587-96. PMID 16714591 DOI: 10.1128/Iai.01644-05  0.379
2005 McCarthy TR, Torrelles JB, MacFarlane AS, Katawczik M, Kutzbach B, Desjardin LE, Clegg S, Goldberg JB, Schlesinger LS. Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages. Molecular Microbiology. 58: 774-90. PMID 16238626 DOI: 10.1111/J.1365-2958.2005.04862.X  0.403
2004 Ferguson JS, Weis JJ, Martin JL, Schlesinger LS. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infection and Immunity. 72: 2564-73. PMID 15102764  0.335
2003 Brown RM, Cruz O, Brennan M, Gennaro ML, Schlesinger L, Skeiky YA, Hoft DF. Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination. The Journal of Infectious Diseases. 187: 513-7. PMID 12552438 DOI: 10.1086/368096  0.338
2002 DesJardin LE, Kaufman TM, Potts B, Kutzbach B, Yi H, Schlesinger LS. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor. Microbiology (Reading, England). 148: 3161-71. PMID 12368450 DOI: 10.1099/00221287-148-10-3161  0.37
2002 Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. Journal of Immunology (Baltimore, Md. : 1950). 168: 1309-14. PMID 11801670  0.314
1998 Schlesinger LS. Mycobacterium tuberculosis and the complement system. Trends in Microbiology. 6: 47-9; discussion 49-. PMID 9507637 DOI: 10.1016/S0966-842X(97)01203-1  0.343
1996 Kusner DJ, Hall CF, Schlesinger LS. Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages Journal of Experimental Medicine. 184: 585-595. PMID 8760812 DOI: 10.1084/Jem.184.2.585  0.341
Low-probability matches (unlikely to be authored by this person)
2018 Locke LW, Crouser ED, White P, Julian MW, Guirado Caceres E, Papp AC, Le VT, Sadee W, Schlesinger LS. IL-13-regulated Macrophage Polarization during Granuloma Formation in an In Vitro Human Sarcoidosis Model. American Journal of Respiratory Cell and Molecular Biology. PMID 30134122 DOI: 10.1165/rcmb.2018-0053OC  0.3
2009 Sow FB, Alvarez GR, Gross RP, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. Journal of Leukocyte Biology. 86: 1247-58. PMID 19652026 DOI: 10.1189/Jlb.1208719  0.3
2014 Ni B, Rajaram MV, Lafuse WP, Landes MB, Schlesinger LS. Mycobacterium tuberculosis decreases human macrophage IFN-γ responsiveness through miR-132 and miR-26a. Journal of Immunology (Baltimore, Md. : 1950). 193: 4537-47. PMID 25252958 DOI: 10.4049/Jimmunol.1400124  0.299
2022 Carless MA, Schlesinger LS. Mycobacterium tuberculosis remodels host transcriptome. Nature Microbiology. 7: 189-190. PMID 35102305 DOI: 10.1038/s41564-021-01056-x  0.297
2019 Elkington P, Lerm M, Kapoor N, Mahon R, Pienaar E, Huh D, Kaushal D, Schlesinger LS. In Vitro Granuloma Models of Tuberculosis: Potential and Challenges. The Journal of Infectious Diseases. PMID 30929010 DOI: 10.1093/Infdis/Jiz020  0.296
2008 Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. Journal of Immunology (Baltimore, Md. : 1950). 180: 7847-58. PMID 18523248 DOI: 10.4049/Jimmunol.180.12.7847  0.296
2018 Hoang KV, Rajaram MVS, Curry HM, Gavrilin MA, Wewers MD, Schlesinger LS. Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During Phagocytosis by Human Mononuclear Phagocytes. Frontiers in Immunology. 9: 561. PMID 29632532 DOI: 10.3389/fimmu.2018.00561  0.295
2017 Crouser ED, White P, Guirado Caceres E, Julian MW, Papp AC, Locke LW, Sadee W, Schlesinger LS. A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent TB Infection. American Journal of Respiratory Cell and Molecular Biology. PMID 28598206 DOI: 10.1165/rcmb.2016-0321OC  0.293
2005 Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, Tibesar E, DesJardin LE, Schlesinger LS. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. The Journal of Experimental Medicine. 202: 987-99. PMID 16203868 DOI: 10.1084/jem.20051239  0.293
2011 Betz BE, Azad AK, Morris JD, Rajaram MV, Schlesinger LS. β-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages. Microbial Pathogenesis. 51: 233-42. PMID 21762773 DOI: 10.1016/j.micpath.2011.06.006  0.292
1998 Kang BK, Schlesinger LS. Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infection and Immunity. 66: 2769-77. PMID 9596746 DOI: 10.1128/iai.66.6.2769-2777.1998  0.291
2017 Ronacher K, van Crevel R, Critchley J, Bremer AA, Schlesinger LS, Kapur A, Basaraba R, Kornfeld H, Restrepo BI. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 2: Underlying biological mechanisms. Chest. PMID 28434937 DOI: 10.1016/J.Chest.2017.02.032  0.291
2012 Guirado E, Arcos J, Knaup R, Reeder R, Betz B, Cotton C, Patel T, Pfaller S, Torrelles JB, Schlesinger LS. Characterization of clinical and environmental Mycobacterium avium spp. isolates and their interaction with human macrophages. Plos One. 7: e45411. PMID 23028991 DOI: 10.1371/journal.pone.0045411  0.29
2020 Rosa BA, Ahmed M, Singh DK, Choreno-Parra JA, Cole J, Jimenez-Alvarez LA, Rodriguez-Reyna TS, Singh B, Golzalez O, Carrion R, Schlesinger LS, Martin J, Zuniga J, Mitreva M, Khader SA, et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Biorxiv : the Preprint Server For Biology. PMID 32793903 DOI: 10.1101/2020.08.06.239798  0.29
2012 Mishra M, Byrd MS, Sergeant S, Azad AK, Parsek MR, McPhail L, Schlesinger LS, Wozniak DJ. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cellular Microbiology. 14: 95-106. PMID 21951860 DOI: 10.1111/J.1462-5822.2011.01704.X  0.289
2015 Achkar J, Beverley P, Boom H, Evans T, Hanekom W, Hickey A, Hoft D, Lakhani D, Lin PL, Ramanathan R, Henao-Restrepo AM, Roy C, Schlesinger L, Seder R, Silver R, et al. Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings. National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014. Vaccine. 33: 3038-3046. DOI: 10.1016/J.Vaccine.2015.03.060  0.288
2017 Pyle CJ, Akhter S, Bao S, Dodd CE, Schlesinger LS, Knoell DL. Zinc Modulates Endotoxin-Induced Human Macrophage Inflammation through ZIP8 Induction and C/EBPβ Inhibition. Plos One. 12: e0169531. PMID 28056086 DOI: 10.1371/Journal.Pone.0169531  0.288
2012 Leander R, Dai S, Schlesinger LS, Friedman A. A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection. Plos Computational Biology. 8: e1002757. PMID 23133361 DOI: 10.1371/journal.pcbi.1002757  0.287
2000 Ferguson JS, Schlesinger LS. Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis. Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 80: 173-84. PMID 11052906 DOI: 10.1054/tuld.2000.0242  0.287
2021 Arnett E, Schlesinger LS. Live and let die: TB control by enhancing apoptosis. Immunity. 54: 1625-1627. PMID 34380059 DOI: 10.1016/j.immuni.2021.07.010  0.285
2014 Canan CH, Gokhale NS, Carruthers B, Lafuse WP, Schlesinger LS, Torrelles JB, Turner J. Characterization of lung inflammation and its impact on macrophage function in aging. Journal of Leukocyte Biology. 96: 473-80. PMID 24935957 DOI: 10.1189/Jlb.4A0214-093Rr  0.282
2021 Abhimanyu, Ontiveros CO, Guerra-Resendez RS, Nishiguchi T, Ladki M, Hilton IB, Schlesinger LS, DiNardo AR. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression. Frontiers in Immunology. 12: 688132. PMID 34163486 DOI: 10.3389/fimmu.2021.688132  0.282
2009 Chiu HC, Kulp SK, Soni S, Wang D, Gunn JS, Schlesinger LS, Chen CS. Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrobial Agents and Chemotherapy. 53: 5236-44. PMID 19805568 DOI: 10.1128/Aac.00555-09  0.282
2008 Ernst JD, Lewinsohn DM, Behar S, Blythe M, Schlesinger LS, Kornfeld H, Sette A. Meeting Report: NIH Workshop on the Tuberculosis Immune Epitope Database. Tuberculosis (Edinburgh, Scotland). 88: 366-70. PMID 18068490 DOI: 10.1016/J.Tube.2007.11.002  0.282
2014 Azad AK, Rajaram MV, Schlesinger LS. Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics. Journal of Cytology & Molecular Biology. 1. PMID 24672807 DOI: 10.13188/2325-4653.1000003  0.279
2007 Olakanmi O, Schlesinger LS, Britigan BE. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. Journal of Leukocyte Biology. 81: 195-204. PMID 17038583 DOI: 10.1189/jlb.0606405  0.278
2011 Abdulrahman BA, Khweek AA, Akhter A, Caution K, Kotrange S, Abdelaziz DH, Newland C, Rosales-Reyes R, Kopp B, McCoy K, Montione R, Schlesinger LS, Gavrilin MA, Wewers MD, Valvano MA, et al. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy. 7: 1359-70. PMID 21997369 DOI: 10.4161/Auto.7.11.17660  0.276
2017 Shrestha CL, Assani KD, Rinehardt H, Albastroiu F, Zhang S, Shell R, Amer AO, Schlesinger LS, Kopp BT. Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages. Plos One. 12: e0186169. PMID 28982193 DOI: 10.1371/Journal.Pone.0186169  0.276
1997 Ferguson JS, Gaynor CD, Schlesinger LS. Mononuclear phagocytes in tuberculosis pathogenesis Current Opinion in Infectious Diseases. 10: 190-195. DOI: 10.1097/00001432-199706000-00006  0.275
2022 Carless MA, Schlesinger LS. Author Correction: Mycobacterium tuberculosis remodels host transcriptome. Nature Microbiology. 7: 463. PMID 35217788 DOI: 10.1038/s41564-022-01087-y  0.275
2017 Dodd CE, Schlesinger LS. New concepts in understanding latent tuberculosis. Current Opinion in Infectious Diseases. PMID 28177961 DOI: 10.1097/QCO.0000000000000367  0.275
2010 Sweet L, Singh PP, Azad AK, Rajaram MV, Schlesinger LS, Schorey JS. Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infection and Immunity. 78: 518-26. PMID 19841083 DOI: 10.1128/Iai.00257-09  0.273
2024 Akhter A, Moliva JI, Azad AK, Olmo-Fontánez A, Garcia-Vilanova A, Scordo JM, Gavrilin MA, Diaz PT, Endsley JJ, Weintraub ST, Schlesinger LS, Wewers MD, Torrelles JB. HIV infection impairs the host response to Mycobacterium tuberculosis infection by altering surfactant protein D function in the human lung alveolar mucosa. Mucosal Immunology. PMID 38184074 DOI: 10.1016/j.mucimm.2023.12.003  0.272
2012 Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infection and Immunity. 80: 3343-59. PMID 22825450 DOI: 10.1128/IAI.00443-12  0.272
2012 Dai S, Mohapatra NP, Schlesinger LS, Gunn JS. The acid phosphatase AcpA is secreted in vitro and in macrophages by Francisella spp. Infection and Immunity. 80: 1088-97. PMID 22184418 DOI: 10.1128/IAI.06245-11  0.268
1996 Schlesinger LS. Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Current Topics in Microbiology and Immunology. 215: 71-96. PMID 8791710 DOI: 10.1007/978-3-642-80166-2_4  0.267
2015 Mishra M, Ressler A, Schlesinger LS, Wozniak DJ. Identification of OprF as a Complement Component C3 Binding Acceptor Molecule on the Surface of Pseudomonas aeruginosa. Infection and Immunity. 83: 3006-14. PMID 25964476 DOI: 10.1128/Iai.00081-15  0.267
2013 Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis (Edinburgh, Scotland). 93: 192-7. PMID 23131496 DOI: 10.1016/j.tube.2012.10.003  0.267
2009 Rajaram MV, Butchar JP, Parsa KV, Cremer TJ, Amer A, Schlesinger LS, Tridandapani S. Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway. Plos One. 4: e7919. PMID 19936232 DOI: 10.1371/Journal.Pone.0007919  0.266
2002 Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. Journal of Immunology (Baltimore, Md. : 1950). 169: 3565-73. PMID 12244146  0.266
2021 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Kaushal D, et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Communications Biology. 4: 290. PMID 33674719 DOI: 10.1038/s42003-021-01829-4  0.266
2021 DiNardo AR, Nishiguchi T, Grimm SL, Schlesinger LS, Graviss EA, Cirillo JD, Coarfa C, Mandalakas AM, Heyckendorf J, Kaufmann SHE, Lange C, Netea MG, Van Crevel R. Tuberculosis endotypes to guide stratified host-directed therapy. Med (New York, N.Y.). 2: 217-232. PMID 34693385 DOI: 10.1016/j.medj.2020.11.003  0.264
2006 Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, Schlesinger LS. Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infection and Immunity. 74: 5114-25. PMID 16926403 DOI: 10.1128/IAI.00795-06  0.262
2002 Olakanmi O, Schlesinger LS, Ahmed A, Britigan BE. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. The Journal of Biological Chemistry. 277: 49727-34. PMID 12399453 DOI: 10.1074/jbc.M209768200  0.261
2022 Sharan R, Ganatra SR, Singh DK, Cole J, Foreman TW, Thippeshappa R, Peloquin CA, Shivanna V, Gonzalez O, Day CL, Gandhi NR, Dick EJ, Hall-Ursone S, Mehra S, Schlesinger LS, et al. Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs. The Journal of Clinical Investigation. PMID 35862216 DOI: 10.1172/JCI161564  0.26
2022 Sivangala Thandi R, Radhakrishnan RK, Tripathi D, Paidipally P, Azad AK, Schlesinger LS, Samten B, Mulik S, Vankayalapati R. Retraction Note: Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection. Nature Communications. 13: 6159. PMID 36257939 DOI: 10.1038/s41467-022-33608-y  0.26
2017 Torrelles JB, Schlesinger LS. Integrating Lung Physiology, Immunology, and Tuberculosis. Trends in Microbiology. PMID 28366292 DOI: 10.1016/j.tim.2017.03.007  0.258
2014 Hoang KV, Borteh HM, Rajaram MV, Peine KJ, Curry H, Collier MA, Homsy ML, Bachelder EM, Gunn JS, Schlesinger LS, Ainslie KM. Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection. International Journal of Pharmaceutics. 477: 334-43. PMID 25447826 DOI: 10.1016/J.Ijpharm.2014.10.022  0.257
2004 Crowther JE, Kutala VK, Kuppusamy P, Ferguson JS, Beharka AA, Zweier JL, McCormack FX, Schlesinger LS. Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. Journal of Immunology (Baltimore, Md. : 1950). 172: 6866-74. PMID 15153505 DOI: 10.4049/Jimmunol.172.11.6866  0.257
2013 Restrepo BI, Schlesinger LS. Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinburgh, Scotland). 93: S10-4. PMID 24388642 DOI: 10.1016/S1472-9792(13)70004-0  0.256
2009 Carlson TK, Torrelles JB, Smith K, Horlacher T, Castelli R, Seeberger PH, Crouch EC, Schlesinger LS. Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from Mycobacterium tuberculosis. Glycobiology. 19: 1473-84. PMID 19684355 DOI: 10.1093/Glycob/Cwp122  0.253
2015 Salunke SB, Azad AK, Kapuriya NP, Balada-Llasat JM, Pancholi P, Schlesinger LS, Chen CS. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore. Bioorganic & Medicinal Chemistry. 23: 1935-43. PMID 25818768 DOI: 10.1016/j.bmc.2015.03.041  0.252
2016 Xiao Y, Tang J, Guo H, Zhao Y, Tang R, Ouyang S, Zeng Q, Rappleye CA, Rajaram MV, Schlesinger LS, Tao L, Brown GD, Langdon WY, Li BT, Zhang J. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nature Medicine. PMID 27428899 DOI: 10.1038/Nm.4141  0.251
2006 Ferguson JS, Martin JL, Azad AK, McCarthy TR, Kang PB, Voelker DR, Crouch EC, Schlesinger LS. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infection and Immunity. 74: 7005-9. PMID 17030585 DOI: 10.1128/Iai.01402-06  0.25
2023 Neehus AL, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M, Arango-Franco CA, Philippot Q, Modaresi M, Mohammadzadeh I, Corcini Berndt M, Rinchai D, Le Voyer T, Rosain J, Momenilandi M, ... ... Schlesinger LS, et al. Human inherited CCR2 deficiency underlies progressive polycystic lung disease. Cell. PMID 38157855 DOI: 10.1016/j.cell.2023.11.036  0.25
2018 Clary G, Sasindran S, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. Mycobacterium abscessus Smooth And Rough Morpohotypes Form Antimicrobial-Tolerant Biofilm Phenotypes But Are Killed by Acetic Acid. Antimicrobial Agents and Chemotherapy. PMID 29311080 DOI: 10.1128/Aac.01782-17  0.249
2015 Voskuil MI, Schlesinger LS. Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease. American Journal of Respiratory and Critical Care Medicine. 191: 1103-5. PMID 25978571 DOI: 10.1164/rccm.201503-0424ED  0.246
2018 Locke LW, Kothandaraman S, Tweedle M, Chaney S, Wozniak DJ, Schlesinger LS. Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinburgh, Scotland). 108: 201-210. PMID 29623875 DOI: 10.1016/J.Tube.2018.01.001  0.246
2014 Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes Research and Clinical Practice. 106: 191-9. PMID 25082309 DOI: 10.1016/j.diabres.2014.06.011  0.244
1990 Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. The Journal of Clinical Investigation. 85: 1304-14. PMID 2138634 DOI: 10.1172/JCI114568  0.244
2017 Assani K, Shrestha CL, Robledo-Avila F, Rajaram MV, Partida-Sanchez S, Schlesinger LS, Kopp BT. Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia. Journal of Immunology (Baltimore, Md. : 1950). PMID 28093527 DOI: 10.4049/Jimmunol.1502609  0.235
2011 Day J, Friedman A, Schlesinger LS. Modeling the host response to inhalation anthrax. Journal of Theoretical Biology. 276: 199-208. PMID 21295589 DOI: 10.1016/j.jtbi.2011.01.054  0.234
2009 Chiu HC, Soni S, Kulp SK, Curry H, Wang D, Gunn JS, Schlesinger LS, Chen CS. Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent. Journal of Biomedical Science. 16: 110. PMID 20003180 DOI: 10.1186/1423-0127-16-110  0.233
2023 Pahari S, Arnett E, Simper J, Azad A, Guerrero-Arguero I, Ye C, Zhang H, Cai H, Wang Y, Lai Z, Jarvis N, Lumbreras M, Maselli-Caceres DJ, Peters J, Torrelles JB, ... ... Schlesinger LS, et al. A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases. Biorxiv : the Preprint Server For Biology. PMID 37066199 DOI: 10.1101/2023.04.05.535806  0.231
2021 Scordo JM, Aguillón-Durán GP, Ayala D, Quirino-Cerrillo AP, Rodríguez-Reyna E, Joya-Ayala M, Mora-Guzmán F, Ledezma-Campos E, Villafañez A, Schlesinger LS, Torrelles JB, Turner J, Restrepo BI. Interferon Gamma Release Assays for Detection of Latent Mycobacterium tuberculosis in Elderly Hispanics. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 34389503 DOI: 10.1016/j.ijid.2021.08.014  0.23
2012 Cremer TJ, Fatehchand K, Shah P, Gillette D, Patel H, Marsh RL, Besecker BY, Rajaram MV, Cormet-Boyaka E, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S. MiR-155 induction by microbes/microbial ligands requires NF-κB-dependent de novo protein synthesis. Frontiers in Cellular and Infection Microbiology. 2: 73. PMID 22919664 DOI: 10.3389/Fcimb.2012.00073  0.229
2017 Hoang KV, Adcox HE, Fitch JR, Gordon DM, Curry HM, Schlesinger LS, White P, Gunn JS. AR-13, a Celecoxib Derivative, Directly Kills Francisella In Vitro and Aids Clearance and Mouse Survival In Vivo. Frontiers in Microbiology. 8: 1695. PMID 28955308 DOI: 10.3389/fmicb.2017.01695  0.227
2014 Moliva JI, Rajaram MV, Sidiki S, Sasindran SJ, Guirado E, Pan XJ, Wang SH, Ross P, Lafuse WP, Schlesinger LS, Turner J, Torrelles JB. Molecular composition of the alveolar lining fluid in the aging lung. Age (Dordrecht, Netherlands). 36: 9633. PMID 24584696 DOI: 10.1007/S11357-014-9633-4  0.226
2023 Pahari S, Arnett E, Simper J, Azad A, Guerrero-Arguero I, Ye C, Zhang H, Cai H, Wang Y, Lai Z, Jarvis N, Lumbreras M, Maselli DJ, Peters J, Torrelles JB, ... ... Schlesinger LS, et al. A new tractable method for generating human alveolar macrophage-like cells to study lung inflammatory processes and diseases. Mbio. e0083423. PMID 37288969 DOI: 10.1128/mbio.00834-23  0.226
2019 Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, Mayer-Barber KD, Mhlanga MM, Nemes E, Schlesinger LS, van Crevel R, Vankalayapati R, Xavier RJ, Netea MG. Targeting innate immunity for tuberculosis vaccination. The Journal of Clinical Investigation. 129: 3482-3491. PMID 31478909 DOI: 10.1172/Jci128877  0.224
2016 Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS. Correction: Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis. Plos Pathogens. 12: e1005504. PMID 26960198 DOI: 10.1371/journal.ppat.1005504  0.222
1994 Schlesinger LS, Horwitz MA. A role for natural antibody in the pathogenesis of leprosy: Antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes Infection and Immunity. 62: 280-289. PMID 8262640 DOI: 10.1128/iai.62.1.280-289.1994  0.218
2010 Dai S, Mohapatra NP, Schlesinger LS, Gunn JS. Regulation of francisella tularensis virulence. Frontiers in Microbiology. 1: 144. PMID 21687801 DOI: 10.3389/fmicb.2010.00144  0.218
2016 Hoang KV, Curry H, Collier MA, Borteh H, Bachelder EM, Schlesinger LS, Gunn JS, Ainslie KM. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge. Antimicrobial Agents and Chemotherapy. 60: 2052-62. PMID 26787696 DOI: 10.1128/Aac.02228-15  0.213
2008 Azad AK, Torrelles JB, Schlesinger LS. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. Journal of Leukocyte Biology. 84: 1594-603. PMID 18772280 DOI: 10.1189/jlb.0308192  0.212
2013 Stew SS, Martinez PJ, Schlesinger LS, Restrepo BI. Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity. Tuberculosis (Edinburgh, Scotland). 93: S78-82. PMID 24388654 DOI: 10.1016/S1472-9792(13)70015-5  0.212
2010 Day J, Schlesinger LS, Friedman A. Tuberculosis research: going forward with a powerful "translational systems biology" approach. Tuberculosis (Edinburgh, Scotland). 90: 7-8. PMID 20045665 DOI: 10.1016/j.tube.2009.12.002  0.211
2009 Chiu HC, Yang J, Soni S, Kulp SK, Gunn JS, Schlesinger LS, Chen CS. Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis. Antimicrobial Agents and Chemotherapy. 53: 2998-3002. PMID 19398640 DOI: 10.1128/Aac.00048-09  0.21
2012 Akhter A, Caution K, Abu Khweek A, Tazi M, Abdulrahman BA, Abdelaziz DH, Voss OH, Doseff AI, Hassan H, Azad AK, Schlesinger LS, Wewers MD, Gavrilin MA, Amer AO. Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization. Immunity. 37: 35-47. PMID 22658523 DOI: 10.1016/J.Immuni.2012.05.001  0.209
2019 Leopold Wager CM, Arnett E, Schlesinger LS. Macrophage nuclear receptors: Emerging key players in infectious diseases. Plos Pathogens. 15: e1007585. PMID 30897154 DOI: 10.1371/journal.ppat.1007585  0.208
1991 Schlesinger LS, Horwitz MA. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. The Journal of Experimental Medicine. 174: 1031-8. PMID 1940785 DOI: 10.1084/jem.174.5.1031  0.208
2020 Singh DK, Singh B, Ganatra SR, Gazi M, Cole J, Thippeshappa R, Alfson KJ, Clemmons E, Gonzalez O, Escobedo R, Lee TH, Chatterjee A, Goez-Gazi Y, Sharan R, Gough M, ... ... Schlesinger LS, et al. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nature Microbiology. PMID 33340034 DOI: 10.1038/s41564-020-00841-4  0.208
2023 Piergallini TJ, Scordo JM, Allué-Guardia A, Pino PA, Zhang H, Cai H, Wang Y, Schlesinger LS, Torrelles JB, Turner J. Acute inflammation alters lung lymphocytes and potentiates innate-like behavior in young mouse lung CD8 T cells, resembling lung CD8 T cells from old mice. Journal of Leukocyte Biology. PMID 37196159 DOI: 10.1093/jleuko/qiad060  0.205
2020 Azad AK, Lloyd C, Sadee W, Schlesinger LS. Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines. Frontiers in Cellular and Infection Microbiology. 10: 139. PMID 32322562 DOI: 10.3389/fcimb.2020.00139  0.203
2019 Lafuse WP, Rajaram MVS, Wu Q, Moliva JI, Torrelles JB, Turner J, Schlesinger LS. Identification of an Increased Alveolar Macrophage Subpopulation in Old Mice That Displays Unique Inflammatory Characteristics and Is Permissive to Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 31511357 DOI: 10.4049/Jimmunol.1900495  0.203
2014 Young NA, Wu LC, Burd CJ, Friedman AK, Kaffenberger BH, Rajaram MV, Schlesinger LS, James H, Shupnik MA, Jarjour WN. Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). 151: 66-77. PMID 24525049 DOI: 10.1016/J.Clim.2014.01.006  0.202
2018 Batra J, Hultquist JF, Liu D, Shtanko O, Von Dollen J, Satkamp L, Jang GM, Luthra P, Schwarz TM, Small GI, Arnett E, Anantpadma M, Reyes A, Leung DW, Kaake R, ... ... Schlesinger LS, et al. Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication. Cell. 175: 1917-1930.e13. PMID 30550789 DOI: 10.1016/J.Cell.2018.08.044  0.2
2005 Beharka AA, Crowther JE, McCormack FX, Denning GM, Lees J, Tibesar E, Schlesinger LS. Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity. Journal of Immunology (Baltimore, Md. : 1950). 175: 2227-36. PMID 16081790 DOI: 10.4049/Jimmunol.175.4.2227  0.199
2013 Collier MA, Gallovic MD, Peine KJ, Duong AD, Bachelder EM, Gunn JS, Schlesinger LS, Ainslie KM. Delivery of host cell-directed therapeutics for intracellular pathogen clearance. Expert Review of Anti-Infective Therapy. 11: 1225-35. PMID 24134600 DOI: 10.1586/14787210.2013.845524  0.198
2001 Sigurdarson ST, Field FJ, Schlesinger LS. Esophageal tuberculosis: A rare but not to be forgotten entity [4] American Journal of Medicine. 110: 415-416. PMID 11294181 DOI: 10.1016/S0002-9343(00)00750-6  0.198
2006 Crowther JE, Schlesinger LS. Endocytic pathway for surfactant protein A in human macrophages: binding, clathrin-mediated uptake, and trafficking through the endolysosomal pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology. 290: L334-42. PMID 16169899 DOI: 10.1152/ajplung.00267.2005  0.196
2004 Olakanmi O, Schlesinger LS, Ahmed A, Britigan BE. The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages. Infection and Immunity. 72: 2022-8. PMID 15039322  0.191
2011 Dwivedi V, Manickam C, Patterson R, Dodson K, Murtaugh M, Torrelles JB, Schlesinger LS, Renukaradhya GJ. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Vaccine. 29: 4058-66. PMID 21419162 DOI: 10.1016/J.Vaccine.2011.03.006  0.19
2013 Khweek AA, Caution K, Akhter A, Abdulrahman BA, Tazi M, Hassan H, Majumdar N, Doran A, Guirado E, Schlesinger LS, Shuman H, Amer AO. A bacterial protein promotes the recognition of the Legionella pneumophila vacuole by autophagy. European Journal of Immunology. 43: 1333-44. PMID 23420491 DOI: 10.1002/Eji.201242835  0.186
2014 Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Corrigendum to “Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control” [Tuberculosis 93 (2) (March 2013) 192-197] Tuberculosis. 94: 533. DOI: 10.1016/j.tube.2014.08.006  0.184
2013 Olakanmi O, Kesavalu B, Pasula R, Abdalla MY, Schlesinger LS, Britigan BE. Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrobial Agents and Chemotherapy. 57: 6074-80. PMID 24060870 DOI: 10.1128/AAC.01543-13  0.183
2022 Hoerter A, Arnett E, Schlesinger LS, Pienaar E. Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection. Frontiers in Immunology. 13: 1014515. PMID 36405707 DOI: 10.3389/fimmu.2022.1014515  0.183
2000 Olakanmi O, Britigan BE, Schlesinger LS. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infection and Immunity. 68: 5619-27. PMID 10992462 DOI: 10.1128/IAI.68.10.5619-5627.2000  0.182
2000 DesJardin LE, Schlesinger LS. Identifying Mycobacterium tuberculosis virulence determinants - new technologies for a difficult problem. Trends in Microbiology. 8: 97-100; discussion 1. PMID 10707056 DOI: 10.1016/S0966-842X(99)01696-0  0.182
2009 Wang SH, Pancholi P, Stevenson K, Yakrus MA, Butler WR, Schlesinger LS, Mangino JE. Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infection Control and Hospital Epidemiology. 30: 848-53. PMID 19653819 DOI: 10.1086/599071  0.181
2010 Wang SH, Powell DA, Nagaraja HN, Morris JD, Schlesinger LS, Turner J. Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. Scandinavian Journal of Infectious Diseases. 42: 845-50. PMID 20608764 DOI: 10.3109/00365548.2010.498021  0.179
2018 Restrepo BI, Kleynhans L, Salinas AB, Abdelbary B, Tshivhula H, Aguillón-Durán GP, Kunsevi-Kilola C, Salinas G, Stanley K, Malherbe ST, Maasdorp E, Garcia-Viveros M, Louw I, Garcia-Oropesa EM, Lopez-Alvarenga JC, ... ... Schlesinger LS, et al. Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups. Tuberculosis (Edinburgh, Scotland). 113: 10-18. PMID 30514492 DOI: 10.1016/j.tube.2018.08.007  0.173
2017 Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS, Basaraba R, Kornfeld H, van Crevel R. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes. Part 1: Epidemiology and clinical management. Chest. PMID 28434936 DOI: 10.1016/J.Chest.2017.04.155  0.173
2022 Garcia-Vilanova A, Olmo-Fontánez AM, Moliva JI, Allué-Guardia A, Singh H, Merritt RE, Maselli DJ, Peters JI, Restrepo BI, Wang Y, Schlesinger LS, Turner J, Weintraub ST, Torrelles JB. The aging human lung mucosa: A proteomics study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 35460553 DOI: 10.1093/gerona/glac091  0.173
2022 Restrepo BI, Scordo JM, Aguillón-Durán GP, Ayala D, Quirino-Cerrillo AP, Loera-Salazar R, Cruz-González A, Caso JA, Joya-Ayala M, García-Oropesa EM, Salinas AB, Martinez L, Schlesinger LS, Torrelles JB, Turner J. Differential Role of Type 2 Diabetes as a Risk Factor for Tuberculosis in the Elderly versus Younger Adults. Pathogens (Basel, Switzerland). 11. PMID 36558885 DOI: 10.3390/pathogens11121551  0.173
2002 Mansour MK, Schlesinger LS, Levitz SM. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. Journal of Immunology (Baltimore, Md. : 1950). 168: 2872-9. PMID 11884457 DOI: 10.4049/Jimmunol.168.6.2872  0.17
2016 Tazi MF, Dakhlallah DA, Caution K, Gerber MM, Chang SW, Khalil H, Kopp B, Ahmed A, Krause K, Davis I, Marsh C, Lovett-Racke AE, Schlesinger LS, Cormet-Boyaka E, Amer AO. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages. Autophagy. 0. PMID 27541364 DOI: 10.1080/15548627.2016.1217370  0.169
2018 Johnson MM, Collier MA, Hoang KV, Pino EN, Graham-Gurysh EG, Gallovic MD, Zahid MSH, Chen N, Schlesinger L, Gunn JS, Bachelder EM, Ainslie KM. In vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection. Molecular Pharmaceutics. PMID 30296381 DOI: 10.1021/Acs.Molpharmaceut.8B00802  0.168
2015 Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, Schlesinger LS. γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). Journal of Immunology (Baltimore, Md. : 1950). 195: 2019-29. PMID 26202986 DOI: 10.4049/jimmunol.1402005  0.166
1994 Gaynor CD, Clark RA, Koontz FP, Emler S, Hirschel B, Schlesinger LS. Disseminated Mycobacterium genavense infection in two patients with AIDS. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 18: 455-7. PMID 7516719 DOI: 10.1093/clinids/18.3.455  0.165
2019 Lange SM, McKell MC, Schmidt SM, Zhao J, Crowther RR, Green LC, Bricker RL, Arnett E, Köhler SE, Schlesinger LS, Setchell KDR, Qualls JE. L-Arginine Synthesis from L-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo. Journal of Immunology (Baltimore, Md. : 1950). PMID 30710047 DOI: 10.4049/jimmunol.1801569  0.163
2022 Torrelles JB, Restrepo BI, Bai Y, Ross C, Schlesinger LS, Turner J. The Impact of Aging on the Lung Alveolar Environment, Predetermining Susceptibility to Respiratory Infections. Frontiers in Aging. 3: 818700. PMID 35821836 DOI: 10.3389/fragi.2022.818700  0.161
2020 Oladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allué-Guardia A, Olmo-Fontánez A, Gautam S, Garcia-Vilanova A, Ye C, Chiem K, Headley C, Dwivedi V, Parodi LM, Alfson KJ, ... ... Schlesinger LS, et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nature Communications. 11: 6122. PMID 33257679 DOI: 10.1038/s41467-020-19891-7  0.156
2008 Wang SH, Mangino JE, Stevenson K, Yakrus MA, Cooksey R, Butler WR, Healy M, Wise MG, Schlesinger LS, Pancholi P. Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreak. Journal of Clinical Microbiology. 46: 1850-3. PMID 18367564 DOI: 10.1128/Jcm.02079-07  0.153
2013 Young NA, Friedman AK, Kaffenberger B, Rajaram MV, Birmingham DJ, Rovin BH, Hebert LA, Schlesinger LS, Wu LC, Jarjour WN. Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Molecular Immunology. 54: 23-31. PMID 23178823 DOI: 10.1016/j.molimm.2012.10.026  0.152
2018 Assani K, Shrestha CL, Rinehardt H, Zhang S, Robledo-Avila F, Wellmerling J, Partida-Sanchez S, Cormet-Boyaka E, Reynolds SD, Schlesinger LS, Kopp BT. AR-13 reduces antibiotic-resistant bacterial burden in cystic fibrosis phagocytes and improves cystic fibrosis transmembrane conductance regulator function. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30366849 DOI: 10.1016/J.Jcf.2018.10.010  0.148
2020 Locke LW, Schlesinger LS, Crouser ED. Current Sarcoidosis Models and the Importance of Focusing on the Granuloma. Frontiers in Immunology. 11: 1719. PMID 32849608 DOI: 10.3389/fimmu.2020.01719  0.146
2000 Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. The Journal of Experimental Medicine. 191: 115-28. PMID 10620610 DOI: 10.1084/Jem.191.1.115  0.145
2023 Djurkovic MA, Leavitt CG, Arnett E, Kriachun V, Martinez-Sobrido L, Titone R, Sherwood LJ, Hayhurst A, Schlesinger LS, Shtanko O. Ebola virus uses tunneling nanotubes as an alternate route of dissemination. The Journal of Infectious Diseases. PMID 37723997 DOI: 10.1093/infdis/jiad400  0.144
1999 George SL, Schlesinger LS. Mycobacterium neoaurum--an unusual cause of infection of vascular catheters: case report and review. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 28: 682-3. PMID 10194099 DOI: 10.1086/517216  0.144
2015 Young N, Rosol T, Schlesinger L, Cope F, Toribio R, Jarjour W. OP0154 Manocept, A Derivative of FDA-Approved 99MTC-Tilmanocept, Exhibits Diagnostic Potential by Specifically Identifying Macrophages in Rheumatoid Arthritis: A Novel Application of an Existing Drug Annals of the Rheumatic Diseases. 74: 127.1-127. DOI: 10.1136/annrheumdis-2015-eular.4876  0.14
2021 Scordo JM, Aguillón-Durán GP, Ayala D, Quirino-Cerrillo AP, Rodríguez-Reyna E, Mora-Guzmán F, Caso JA, Ledezma-Campos E, Schlesinger LS, Torrelles JB, Turner J, Restrepo BI. A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor. Plos One. 16: e0255194. PMID 34324578 DOI: 10.1371/journal.pone.0255194  0.138
2021 Singh DK, Singh B, Ganatra SR, Gazi M, Cole J, Thippeshappa R, Alfson KJ, Clemmons E, Gonzalez O, Escobedo R, Lee TH, Chatterjee A, Goez-Gazi Y, Sharan R, Gough M, ... ... Schlesinger LS, et al. Author Correction: Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nature Microbiology. PMID 33462437 DOI: 10.1038/s41564-021-00867-2  0.135
1987 Schlesinger LS, Ross SC, Schaberg DR. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine. 66: 148-56. PMID 3821485 DOI: 10.1097/00005792-198703000-00006  0.135
2014 Chesarino NM, Hach JC, Chen JL, Zaro BW, Rajaram MV, Turner J, Schlesinger LS, Pratt MR, Hang HC, Yount JS. Chemoproteomics reveals Toll-like receptor fatty acylation. Bmc Biology. 12: 91. PMID 25371237 DOI: 10.1186/S12915-014-0091-3  0.134
2020 Toribio RE, Young N, Schlesinger LS, Cope FO, Ralph DA, Jarjour W, Rosol TJ. Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 33107629 DOI: 10.1002/jor.24900  0.132
2017 Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS. Human Genetic Determinants of Viral Diseases. Annual Review of Genetics. PMID 28853921 DOI: 10.1146/Annurev-Genet-120116-023425  0.123
2013 Azad AK, Curtis A, Papp A, Webb A, Knoell D, Sadee W, Schlesinger LS. Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene. Genes and Immunity. 14: 99-106. PMID 23328842 DOI: 10.1038/Gene.2012.61  0.119
2009 Lustberg ME, Schlesinger LS, Mangino JE. Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study". Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 313; author reply 31. PMID 19538067 DOI: 10.1086/600056  0.113
2013 Julian MW, Shao G, Schlesinger LS, Huang Q, Cosmar DG, Bhatt NY, Culver DA, Baughman RP, Wood KL, Crouser ED. Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest. 143: 461-70. PMID 22878868 DOI: 10.1378/chest.12-0383  0.099
2014 Gebreyes WA, Dupouy-Camet J, Newport MJ, Oliveira CJ, Schlesinger LS, Saif YM, Kariuki S, Saif LJ, Saville W, Wittum T, Hoet A, Quessy S, Kazwala R, Tekola B, Shryock T, et al. The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings. Plos Neglected Tropical Diseases. 8: e3257. PMID 25393303 DOI: 10.1371/Journal.Pntd.0003257  0.097
2012 Metz W, Cope F, Hartman R, Joy M, Potter B, Abbruzzese B, Blue M, Rajaram M, Azad A, Schlesinger L. PO-48: Validation of TC 99M Tilmanocept Binding to the Mannose Receptor (CD206) and its Clinical Utility Radiotherapy and Oncology. 104: 36. DOI: 10.1016/S0167-8140(15)34602-8  0.092
2016 Makara MA, Hoang KV, Ganesan LP, Crouser ED, Gunn JS, Turner J, Schlesinger LS, Mohler PJ, Rajaram MV. Cardiac Electrical and Structural Changes During Bacterial Infection: An Instructive Model to Study Cardiac Dysfunction in Sepsis. Journal of the American Heart Association. 5. PMID 27620887 DOI: 10.1161/Jaha.116.003820  0.088
2015 Azad AK, Schlesinger LS. Mannose receptor (CD206)-mediated imaging in sentinel lymph node localization Clinical and Translational Imaging. 3: 237-245. DOI: 10.1007/s40336-015-0117-z  0.082
2016 Cope FO, Abbruzzese B, Sanders J, Metz W, Sturms K, Ralph D, Blue M, Zhang J, Bracci P, Bshara W, Behr S, Maurer T, Williams K, Walker J, Beverly A, ... ... Schlesinger LS, et al. Corrigendum to the inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach [Nucl Med Biol 43 (2016) 215-225]. Nuclear Medicine and Biology. 43: 837. PMID 27866590 DOI: 10.1016/J.Nucmedbio.2016.10.001  0.041
1989 Davis M, Schlesinger LS, Sorenson CA. Temporal specificity of fear conditioning: Effects of different conditioned stimulus--unconditioned stimulus intervals on the fear-potentiated startle effect. Journal of Experimental Psychology: Animal Behavior Processes. 15: 295-310. DOI: 10.1037/0097-7403.15.4.295  0.013
2006 SCHLESINGER LS, FARBER SH. Overcoming Addiction: Three Physicians' Stories Pediatric News. 40: 46. DOI: 10.1016/S0031-398X(06)70843-8  0.01
1979 Adkins E, Schlesinger L. Androgens and the social behavior of male and female lizards (Anolis carolinensis). Hormones and Behavior. 13: 139-52. PMID 575950 DOI: 10.1016/0018-506X(79)90053-9  0.01
Hide low-probability matches.